Document is current
Any future updates will be listed below
-
Authors
Ianiro, Gianluca https://orcid.org/0000-0002-8318-0515
Punčochář, Michal
Karcher, Nicolai https://orcid.org/0000-0001-7894-8182
Porcari, Serena
Armanini, Federica
Asnicar, Francesco https://orcid.org/0000-0003-3732-1468
Beghini, Francesco https://orcid.org/0000-0002-8105-9607
Blanco-Míguez, Aitor https://orcid.org/0000-0001-7386-5572
Cumbo, Fabio
Manghi, Paolo https://orcid.org/0000-0003-0846-6529
Pinto, Federica https://orcid.org/0000-0002-4539-4811
Masucci, Luca
Quaranta, Gianluca
De Giorgi, Silvia https://orcid.org/0000-0002-9498-800X
Sciumè, Giusi Desirè
Bibbò, Stefano
Del Chierico, Federica
Putignani, Lorenza https://orcid.org/0000-0003-0134-2830
Sanguinetti, Maurizio https://orcid.org/0000-0002-9780-7059
Gasbarrini, Antonio
Valles-Colomer, Mireia https://orcid.org/0000-0002-1988-6054
Cammarota, Giovanni https://orcid.org/0000-0002-3626-6148
Segata, Nicola https://orcid.org/0000-0002-1583-5794
- License Information
-
More Information
Article History
Received: 8 October 2021
Accepted: 21 July 2022
First Online: 15 September 2022
Competing interests
: A.G. reports personal fees for consultancy for Eisai S.r.l., 3PSolutions, Real Time Meeting, Fondazione Istituto Danone, Sinergie S.r.l. Board MRGE and SanofiS.p.A; personal fees for acting as a speaker for Takeda S.p.A, AbbVie and Sandoz S.p.A; and personal fees for acting on advisory boards for VSL3 and Eisai. G.C. has received personal fees for acting as advisor for Ferring Therapeutics. G.I. has received personal fees for acting as speaker for Biocodex, Danone, Sofar, Malesci, Metagenics and Tillotts Pharma, and for acting as consultant/advisor for Ferring Therapeutics, Giuliani, Metagenics and Tillotts Pharma. N.S. reports consultancy and/or SAB contracts with Zoe, Roche, Ysopia, and Freya, Alia Therapeutics, speaker fees by Illumina, and is cofounder of PreBiomics. The other authors have no potential competing interest to disclose.
